Summary
Acute administration of phencyclidine hydrochloride (PCP) resulted in a dose-responsive decrease in the conversion of3H-tryptophan to3H-serotonin (3H-5-HT) in rat forebrain. Subsequent experiments measured the effect of a subthreshold dose of PCP (4 mg/kg) daily for one, seven, or fourteen days on this index of 5-HT turnover. Although single administration again had no effect at this dose, repeated administration for seven days resulted in a 37% decrease in 5-HT turnover. However, after fourteen days of administration this index was not significantly different from saline controls. The possible significance of these findings are discussed in relation to reported alterations in PCP-induced behaviors observed with chronic administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Castellani, S., Adams, P. M.: Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharmacol. (in press, 1981).
Chait, L. D., Balster, R. L.: The effects of acute and chronic phencyclidine on schedule-controlled behavior in the squirrel monkey. J. Pharmacol. Exp. Ther.204, 77–87 (1978).
Corrodi, H., Fuxe, K.: Decreased turnover in central 5-HT nerve terminals induced by antidepressant drugs of the imipramine type. Eur. J. Pharmacol.7, 56–59 (1969).
Doherty, J., Simonovic, M., So, R., Meltzer, H. Y.: The effect of phencyclidine on dopamine synthesis and metabolism in the rat striatum. Eur. J. Pharmacol.65, 139–149 (1980).
Fibiger, H. C., Miller, J. J.: An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphé nucleus to the substantia nigra in the rat. Neurosci.2, 975–987 (1977).
Fuller, R. W., Perry, K. W., Molloy, B. B.: Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci.15, 1161–1171 (1974).
Grahame-Smith, D. G.: Studiesin vivo on the relationships between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem.18, 1053–1066 (1971).
Herve, D., Simon, H., Blanc, G., Lisoprawski, A., LeMoal, M.: Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphé lesion in the rat. Neurosci. Lett.15, 127–133 (1979).
Johnson, K. M., Balster, R. L.: Acute and chronic phencyclidine administration: relationships between biodispositional factors and behavioral effects. S.A.A.M.2, 131–142 (1981).
Johnson, K. M., Dewey, W. L.: The effect of Δ9-tetrahydrocannabinol on the conversion of3H-tryptophan to 5-3H-hydroxytryptamine in the mouse brain. J. Pharmacol. Exp. Ther.207, 140–150 (1978).
Johnson, K. M., Oeffinger, K. C.: The effect of phencyclidine on dopamine metabolism in the mouse brain. Life Sci.28, 361–369 (1981).
Lin, R. C., Neff, H. H., Ngai, S. H., Costa, E.: Turnover rates of serotonin and norepinephrine in brain of normal and pargyline treated rats. Life Sci.8, 1077–1084 (1969).
Martin, J. R., Berman, M. H., Krewsun, I., Small, S. F.: Phencyclidine-induced stereotyped behavior and serotonergic syndrome in rats. Life Sci.24, 1699–1704 (1979).
Misra, A. L., Pontani, R. B., Bartolomeo, J. G.: Disposition of3H-phencyclidine in the rat after single and multiple doses. Life Sci.27, 2501–2508 (1980).
Murray, T. F.: Effect of phencyclidine on operant behavior in the rat: biphasic effect and tolerance development. Life Sci.22, 195–202 (1978).
Pinchasi, I., Maayani, S., Egozi, Y., Sokolovsky, M.: On the interaction of drugs with the cholinergic nervous system. II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs. Psychopharmacol.56, 37–40 (1978).
Raji, S. N., Guyenet, P. G.: Effects of phencyclidine on the spontaneous activity of monoaminergic neurons. Eur. J. Pharmacol.63, 229–233 (1980).
Segal, D. S.: Differential effects of p-chlorophenylalanine on amphetamine induced locomotion and stereotypy. Brain Res.116, 267–276 (1976).
Smith, R. C., Briggs, C., Vroulis, G., Brinkman, S.: Effects of chronic administration of phencyclidine in stereotyped and ataxic behaviors in the rat. Life Sci.28, 1163–1174 (1981).
Smith, R. C., Meltzer, H. Y., Arora, R. C., Davis, J. M.: Effects of phencyclidine on3H-catecholamine and3H-serotonin uptake in synaptosomal preparations from rat brains. Biochem. Pharmacol.26, 1435–1439 (1977).
Smith, R. C., Taylor, D., Ho, B. T., Leelavathi, D.: Effects of acute and chronic administration of phencyclidine on tyrosine hydroxylase activity in the rat striatum. J. Neural Transm.48, 289–295 (1980).
Sturgeon, R. D., Fessler, R. G., Meltzer, H. Y.: Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur. J. Pharmacol.59, 169–179 (1979).
Tonge, S. R.: Variation in hydroxytryptamine metabolism in the rat: effects on the neurochemical response to phencyclidine. J. Pharm. Pharmacol.23, 71 (1971).
Tonge, S. R., Leonard, B. E.: The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxytryptamine in the brain. Life Sci.8 (Part 1), 805–814 (1969).
Udenfriend, S., Weissbach, H., Bogdanski, D. F.: Fluorescence characteristics of 5-hydroxytryptamine (serotonin). Science122, 972–973 (1955).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, K.M. Acute and chronic phencyclidine administration: Effects on the conversion of3H-tryptophan to3H-serotonin in rat forebrain. J. Neural Transmission 53, 179–186 (1982). https://doi.org/10.1007/BF01243409
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01243409